These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30833417)

  • 1. Base excision repair deficiency signatures implicate germline and somatic
    Thibodeau ML; Zhao EY; Reisle C; Ch'ng C; Wong HL; Shen Y; Jones MR; Lim HJ; Young S; Cremin C; Pleasance E; Zhang W; Holt R; Eirew P; Karasinska J; Kalloger SE; Taylor G; Majounie E; Bonakdar M; Zong Z; Bleile D; Chiu R; Birol I; Gelmon K; Lohrisch C; Mungall KL; Mungall AJ; Moore R; Ma YP; Fok A; Yip S; Karsan A; Huntsman D; Schaeffer DF; Laskin J; Marra MA; Renouf DJ; Jones SJM; Schrader KA
    Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30833417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-Cancer Interrogation of
    Paller CJ; Tukachinsky H; Maertens A; Decker B; Sampson JR; Cheadle JP; Antonarakis ES
    JCO Precis Oncol; 2024 Feb; 8():e2300251. PubMed ID: 38394468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoallelic deleterious MUTYH germline variants as a driver for tumorigenesis.
    Barreiro RAS; Sabbaga J; Rossi BM; Achatz MIW; Bettoni F; Camargo AA; Asprino PF; A F Galante P
    J Pathol; 2022 Feb; 256(2):214-222. PubMed ID: 34816434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers.
    Georgeson P; Pope BJ; Rosty C; Clendenning M; Mahmood K; Joo JE; Walker R; Hutchinson RA; Preston S; Como J; Joseland S; Win AK; Macrae FA; Hopper JL; Mouradov D; Gibbs P; Sieber OM; O'Sullivan DE; Brenner DR; Gallinger S; Jenkins MA; Winship IM; Buchanan DD
    Gut; 2021 Nov; 70(11):2138-2149. PubMed ID: 33414168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic c.34G>T KRAS mutation: a new prescreening test for MUTYH-associated polyposis?
    Aimé A; Coulet F; Lefevre JH; Colas C; Cervera P; Flejou JF; Lascols O; Soubrier F; Parc Y
    Cancer Genet; 2015; 208(7-8):390-5. PubMed ID: 26056087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenomas from individuals with pathogenic biallelic variants in the
    Walker R; Joo JE; Mahmood K; Clendenning M; Como J; Preston SG; Joseland S; Pope BJ; Medeiros ABD; Murillo BV; Pachter N; Sweet K; Spigelman AD; Groves A; Gleeson M; Bernatowicz K; Poplawski N; Andrews L; Healey E; Gallinger S; Grant RC; Win AK; Hopper JL; Jenkins MA; Torrezan GT; Rosty C; Macrae FA; Winship IM; Buchanan DD; Georgeson P
    medRxiv; 2024 Aug; ():. PubMed ID: 39148833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of germline MUTYH mutations among Lynch-like syndrome patients.
    Castillejo A; Vargas G; Castillejo MI; Navarro M; Barberá VM; González S; Hernández-Illán E; Brunet J; Ramón y Cajal T; Balmaña J; Oltra S; Iglesias S; Velasco A; Solanes A; Campos O; Sánchez Heras AB; Gallego J; Carrasco E; González Juan D; Segura A; Chirivella I; Juan MJ; Tena I; Lázaro C; Blanco I; Pineda M; Capellá G; Soto JL
    Eur J Cancer; 2014 Sep; 50(13):2241-50. PubMed ID: 24953332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying colorectal cancer caused by biallelic MUTYH pathogenic variants using tumor mutational signatures.
    Georgeson P; Harrison TA; Pope BJ; Zaidi SH; Qu C; Steinfelder RS; Lin Y; Joo JE; Mahmood K; Clendenning M; Walker R; Amitay EL; Berndt SI; Brenner H; Campbell PT; Cao Y; Chan AT; Chang-Claude J; Doheny KF; Drew DA; Figueiredo JC; French AJ; Gallinger S; Giannakis M; Giles GG; Gsur A; Gunter MJ; Hoffmeister M; Hsu L; Huang WY; Limburg P; Manson JE; Moreno V; Nassir R; Nowak JA; Obón-Santacana M; Ogino S; Phipps AI; Potter JD; Schoen RE; Sun W; Toland AE; Trinh QM; Ugai T; Macrae FA; Rosty C; Hudson TJ; Jenkins MA; Thibodeau SN; Winship IM; Peters U; Buchanan DD
    Nat Commun; 2022 Jun; 13(1):3254. PubMed ID: 35668106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational signature analysis identifies MUTYH deficiency in colorectal cancers and adrenocortical carcinomas.
    Pilati C; Shinde J; Alexandrov LB; Assié G; André T; Hélias-Rodzewicz Z; Ducoudray R; Le Corre D; Zucman-Rossi J; Emile JF; Bertherat J; Letouzé E; Laurent-Puig P
    J Pathol; 2017 May; 242(1):10-15. PubMed ID: 28127763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MUTYH exon 7 and 13 mutations associated with colorectal cancer (MAP syndrome) are not commonly associated with sporadic pancreatic cancer.
    Smith LM; Sharif S; Brand R; Fink E; Lamb J; Whitcomb DC
    Pancreatology; 2009; 9(6):793-6. PubMed ID: 20110747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G > T prescreening followed by MUTYH hotspot analysis in formalin-fixed paraffin-embedded tissue.
    van Puijenbroek M; Nielsen M; Tops CM; Halfwerk H; Vasen HF; Weiss MM; van Wezel T; Hes FJ; Morreau H
    Clin Cancer Res; 2008 Jan; 14(1):139-42. PubMed ID: 18172263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial cancer may be part of the MUTYH-associated polyposis cancer spectrum.
    Villy MC; Masliah-Planchon J; Buecher B; Beaulaton C; Vincent-Salomon A; Stoppa-Lyonnet D; Colas C
    Eur J Med Genet; 2022 Jan; 65(1):104385. PubMed ID: 34775073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of the base excision repair gene MUTYH in sporadic colorectal cancer.
    Kuno T; Matsubara N; Tsuda S; Kobayashi M; Hamanaka M; Yamagishi D; Tsukamoto K; Yamano T; Noda M; Ikeuchi H; Kim S; Tamura K; Tomita N
    Oncol Rep; 2012 Aug; 28(2):473-80. PubMed ID: 22641385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial cancer and somatic G>T KRAS transversion in patients with constitutional MUTYH biallelic mutations.
    Tricarico R; Bet P; Ciambotti B; Di Gregorio C; Gatteschi B; Gismondi V; Toschi B; Tonelli F; Varesco L; Genuardi M
    Cancer Lett; 2009 Feb; 274(2):266-70. PubMed ID: 18980800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First report of medulloblastoma in a patient with MUTYH-associated polyposis.
    Villy MC; Warcoin M; Filser M; Buecher B; Golmard L; Suybeng V; Schwartz M; Bieche I; Vacher S; Laurence V; Bourdeaut F; Bernier M; Gutman T; Stoppa-Lyonnet D; Masliah-Planchon J; Colas C
    Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12929. PubMed ID: 37524406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis.
    Lejeune S; Guillemot F; Triboulet JP; Cattan S; Mouton C; ; Porchet N; Manouvrier S; Buisine MP
    Hum Mutat; 2006 Oct; 27(10):1064. PubMed ID: 16941501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited MUTYH mutations cause elevated somatic mutation rates and distinctive mutational signatures in normal human cells.
    Robinson PS; Thomas LE; Abascal F; Jung H; Harvey LMR; West HD; Olafsson S; Lee BCH; Coorens THH; Lee-Six H; Butlin L; Lander N; Truscott R; Sanders MA; Lensing SV; Buczacki SJA; Ten Hoopen R; Coleman N; Brunton-Sim R; Rushbrook S; Saeb-Parsy K; Lalloo F; Campbell PJ; Martincorena I; Sampson JR; Stratton MR
    Nat Commun; 2022 Jul; 13(1):3949. PubMed ID: 35803914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative Damage in Sporadic Colorectal Cancer: Molecular Mapping of Base Excision Repair Glycosylases MUTYH and hOGG1 in Colorectal Cancer Patients.
    Kavec MJ; Urbanova M; Makovicky P; Opattová A; Tomasova K; Kroupa M; Kostovcikova K; Siskova A; Navvabi N; Schneiderova M; Vymetalkova V; Vodickova L; Vodicka P
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No association between MUTYH and MSH6 germline mutations in 64 HNPCC patients.
    Steinke V; Rahner N; Morak M; Keller G; Schackert HK; Görgens H; Schmiegel W; Royer-Pokora B; Dietmaier W; Kloor M; Engel C; Propping P; Aretz S;
    Eur J Hum Genet; 2008 May; 16(5):587-92. PubMed ID: 18301448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUTYH-associated tumor syndrome: The other face of MAP.
    Magrin L; Fanale D; Brando C; Corsini LR; Randazzo U; Di Piazza M; Gurrera V; Pedone E; Bazan Russo TD; Vieni S; Pantuso G; Russo A; Bazan V
    Oncogene; 2022 Apr; 41(18):2531-2539. PubMed ID: 35422474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.